Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novo Nordisk Faced Tough Decision in Greece: Cut Prices And Make A Loss Or Oppose Government Plans

This article was originally published in The Pink Sheet Daily

Executive Summary

Danish drug maker turns up pressure on Greek government to reverse its price cut demands.

You may also be interested in...



Greece, Slashing Drug Budget Via Cuts And Non-Payment, Backs Generics

Greece has slashed its pharmaceutical budget in half by price cuts and withholding payments, but it is now turning to generics to fulfill its citizens’ health care needs.

European Price Cuts Likely To Be Above Normal This Year, Says EFPIA President Witty

GSK's Witty urges European companies to work with government payers.

European Price Cuts Likely To Be Above Normal This Year, Says EFPIA President Witty

GSK's Witty urges European companies to work with government payers.

Related Content

Topics

UsernamePublicRestriction

Register

PS070782

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel